Ophidion has developed a proprietary carrier technology that enhances the penetration of drugs and large molecules into the brain. They are focused on developing a pipeline of products to treat neurodegenerative diseases and anxiety-related disorders by delivering gene therapy and other macromolecules to the central nervous system. Ophidion's advanced program includes a companion biomarker diagnostic to select the appropriate patient population for clinical trials.